ICRA has raised Viyash Scientific's credit rating to AA/Stable on April 22, 2026, implying improved financial health and stability for bank loans. The previous AAA rating for bank loans was withdrawn.

Viyash Scientific plans to achieve a 15% yearly expansion by FY26, primarily focusing on Active Pharmaceutical Ingredients (APIs). The firm is confident in its robust financial structure to reach these ambitious targets.

Viyash Scientific's Q4 revenue for FY26 increased by 19% compared to the previous year, reaching 9.2 billion INR. The company saw a significant boost in earnings before interest, taxes, depreciation, and amortization (EBITDA), which rose by 64%, amounting to 2.01 billion INR. The improved margin was at 21.7%, and the net debt-to-EBITDA ratio has reduced to 0.2x, indicating a strong financial performance.

Viyash Scientific reported a Q4 net profit of ₹66.4 crore on ₹920 crore revenue. The company's FY25-26 revenue reached an impressive ₹3,420.3 crore, largely due to successful integration efforts, resulting in a net profit of ₹224.6 crore for the financial year.

Viyash Scientific significantly improved its financial performance in Q4, turning a ₹262 million loss into a profit of ₹521 million year-over-year. This impressive turnaround was accompanied by a 19% revenue growth, with Q4 revenue reaching ₹9.2 billion compared to ₹7.7 billion in the same period last year.

On May 19, 2026, Viyash Scientific Ltd will convene a board meeting to evaluate their FY2026 financial results and propose a dividend distribution. In accordance with SEBI guidelines and company policy, trading for Viyash Scientific remains suspended until May 21, 2026.

Viyash Scientific's long-term rating has been boosted by India Ratings to 'IND AA/Stable', a testament to its enhanced creditworthiness. Additionally, the short-term rating has been raised to 'IND A1+'. This move indicates a stronger financial standing for the company.

Viyash Scientific has been upgraded to ICRA AA (Stable) for a Rs. 185 crore loan, signifying improved creditworthiness compared to the IND A (Positive) rating it previously held from India Ratings in January 2025.